Terms: = Liver cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Clinical Outcome
5 results:
1. Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters.
Lionti S; Reggiani Bonetti L; Bettelli S; Spallanzani A; Gelsomino F; Barresi V
Hum Pathol; 2018 Aug; 78():115-124. PubMed ID: 29715463
[TBL] [Abstract] [Full Text] [Related]
2. Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma.
Nutthasirikul N; Limpaiboon T; Leelayuwat C; Patrakitkomjorn S; Jearanaikoon P
Int J Oncol; 2013 Apr; 42(4):1181-8. PubMed ID: 23404110
[TBL] [Abstract] [Full Text] [Related]
3. High-grade transformation of adenoid cystic carcinomas: a study of the expression of GLUT1 glucose transporter and of mitochondrial antigen.
Bonfitto VL; Demasi AP; Costa AF; Bonfitto JF; Araujo VC; Altemani A
J Clin Pathol; 2010 Jul; 63(7):615-9. PubMed ID: 20530155
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin.
Italiano A; Toulmonde M; Stoeckle E; Kind M; Kantor G; Coindre JM; Bui B
Ann Oncol; 2010 Sep; 21(9):1915-1921. PubMed ID: 20167595
[TBL] [Abstract] [Full Text] [Related]
5. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.
Plaat BE; Hollema H; Molenaar WM; Torn Broers GH; Pijpe J; Mastik MF; Hoekstra HJ; van den Berg E; Scheper RJ; van der Graaf WT
J Clin Oncol; 2000 Sep; 18(18):3211-20. PubMed ID: 10986053
[TBL] [Abstract] [Full Text] [Related]
